Human Gene MIR548AD (ENST00000584780.1) from GENCODE V44
  Description: Homo sapiens microRNA 548ad (MIR548AD), microRNA. (from RefSeq NR_039629)
RefSeq Summary (NR_039629): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000584780.1
Gencode Gene: ENSG00000265301.1
Transcript (Including UTRs)
   Position: hg38 chr2:35,471,405-35,471,486 Size: 82 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr2:35,471,405-35,471,486)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerGencodeHGNCLynxMalacards
PubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  HZ408564 - JP 2015528002-A/1161: CHIRAL CONTROL.
LG051898 - KR 1020150036642-A/1164: CHIRAL CONTROL.
HZ483224 - JP 2015535430-A/3730: TERMINALLY MODIFIED RNA.
HZ483284 - JP 2015535430-A/3790: TERMINALLY MODIFIED RNA.
HZ793155 - JP 2016504050-A/4900: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
HZ793215 - JP 2016504050-A/4960: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JC515887 - Sequence 6140 from Patent WO2014113089.
JC515947 - Sequence 6200 from Patent WO2014113089.
LQ073475 - Sequence 3799 from Patent EP2964234.
LQ073535 - Sequence 3859 from Patent EP2964234.
MA646976 - JP 2017113010-A/4900: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA647036 - JP 2017113010-A/4960: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA734860 - JP 2017140048-A/3730: TERMINALLY MODIFIED RNA.
MA734920 - JP 2017140048-A/3790: TERMINALLY MODIFIED RNA.
JD360161 - Sequence 341185 from Patent EP1572962.
FW364445 - Oligonucleotides for modulating target RNA activity.
HI964946 - Sequence 231 from Patent WO2010139812.
HI966071 - Sequence 391 from Patent WO2010139811.
HI966937 - Sequence 391 from Patent WO2010139810.
HV595347 - JP 2010539959-A/728: Micromirs.
HV753793 - JP 2012509675-A/31: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF.
HV938922 - JP 2011519579-A/1750: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HW915107 - JP 2015504655-A/65: METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIES.
HZ074519 - JP 2013535982-A/610: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083223 - JP 2015513906-A/580: Stem Cell Microparticles.
HZ157904 - JP 2015130862-A/728: Micromirs.
HZ186758 - JP 2015146814-A/507: Oligonucleotides for modulating target RNA activity.
HZ437004 - JP 2015529450-A/580: Stem Cell Microparticles.
HZ482237 - JP 2015535430-A/2743: TERMINALLY MODIFIED RNA.
HZ482245 - JP 2015535430-A/2751: TERMINALLY MODIFIED RNA.
HZ792168 - JP 2016504050-A/3913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
HZ792176 - JP 2016504050-A/3921: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA400984 - Sequence 231 from Patent WO2011080318.
JA401962 - Sequence 231 from Patent WO2011080315.
JA402969 - Sequence 231 from Patent WO2011080316.
JA405600 - Sequence 231 from Patent EP2336353.
JA427338 - Sequence 671 from Patent WO2011072177.
JA429126 - Sequence 231 from Patent WO2011095623.
JA791779 - Sequence 181 from Patent WO2012089772.
JA821229 - Sequence 1750 from Patent EP2285961.
JB022410 - Sequence 252 from Patent WO2013026685.
JB023073 - Sequence 327 from Patent WO2013026684.
JB620704 - Sequence 684 from Patent WO2013063544.
JB751183 - Sequence 65 from Patent WO2013087907.
JC172208 - Sequence 580 from Patent WO2013150303.
JC506848 - Sequence 216 from Patent EP2733220.
JC514900 - Sequence 5153 from Patent WO2014113089.
JC514908 - Sequence 5161 from Patent WO2014113089.
JC573019 - Sequence 580 from Patent WO2014125276.
JC582707 - Sequence 580 from Patent WO2014125277.
JC737960 - Sequence 216 from Patent WO2014075939.
JE954403 - Sequence 580 from Patent WO2015052526.
JE956156 - Sequence 580 from Patent WO2015052527.
LF137908 - JP 2016507550-A/580: Method of Producing Microparticles.
LF160530 - JP 2016513950-A/596: Oligomers with improved off-target profile.
LF160788 - JP 2016513950-A/854: Oligomers with improved off-target profile.
LF162873 - JP 2016513095-A/580: Stem Cell Microparticles and miRNA.
LF953625 - JP 2016534103-A/580: Stem Cell Microparticles and miRNA.
LG005970 - KR 1020150004822-A/580: STEM CELL MICROPARTICLES.
LG053666 - KR 1020150059168-A/580: STEM CELL MICROPARTICLES.
LG240905 - KR 1020160035087-A/580: STEM CELL MICROPARTICLES AND MIRNA.
LP726697 - Sequence 391 from Patent EP2883966.
LP818967 - Sequence 391 from Patent EP3296406.
LP835252 - Sequence 50 from Patent WO2017108535.
LP835253 - Sequence 51 from Patent WO2017108535.
LP835254 - Sequence 52 from Patent WO2017108535.
LP835255 - Sequence 53 from Patent WO2017108535.
LP938909 - Sequence 391 from Patent EP3184651.
LP939559 - Sequence 50 from Patent EP3184646.
LP939560 - Sequence 51 from Patent EP3184646.
LP939561 - Sequence 52 from Patent EP3184646.
LP939562 - Sequence 53 from Patent EP3184646.
LP951926 - Sequence 432 from Patent WO2017157650.
LQ072488 - Sequence 2812 from Patent EP2964234.
LQ072496 - Sequence 2820 from Patent EP2964234.
LQ278470 - Sequence 9 from Patent WO2016066288.
LQ724716 - Sequence 349 from Patent WO2018096084.
LV470990 - JP 2016534036-A/580: Stem Cell Microparticles and miRNA.
LY405412 - KR 1020160117535-A/717: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ234115 - JP 2017184756-A/507: Oligonucleotides for modulating target RNA activity.
MA260651 - JP 2017505623-A/717: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA645989 - JP 2017113010-A/3913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA645997 - JP 2017113010-A/3921: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733873 - JP 2017140048-A/2743: TERMINALLY MODIFIED RNA.
MA733881 - JP 2017140048-A/2751: TERMINALLY MODIFIED RNA.
MS673524 - Sequence 327 from Patent EP3135774.
MS834085 - Sequence 231 from Patent EP3112479.
MS901779 - Sequence 252 from Patent EP3156505.
HZ482206 - JP 2015535430-A/2712: TERMINALLY MODIFIED RNA.
HZ792137 - JP 2016504050-A/3882: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JC514869 - Sequence 5122 from Patent WO2014113089.
LF161061 - JP 2016513950-A/1127: Oligomers with improved off-target profile.
LQ072457 - Sequence 2781 from Patent EP2964234.
MA645958 - JP 2017113010-A/3882: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA733842 - JP 2017140048-A/2712: TERMINALLY MODIFIED RNA.
MA804029 - JP 2018183181-A/4900: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA804089 - JP 2018183181-A/4960: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA803042 - JP 2018183181-A/3913: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA803050 - JP 2018183181-A/3921: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA803011 - JP 2018183181-A/3882: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129680 - Sequence 580 from Patent EP3470073.
MP162603 - Sequence 580 from Patent WO2019069093.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_039629, uc032njn.1
UCSC ID: ENST00000584780.1
RefSeq Accession: NR_039629

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.